[Cutaneous lupus erythematosus, a multidimensional entity]

Area of Science:

• Dermatology
• Rheumatology
• Immunology

Background:

• Cutaneous lupus erythematosus (CLE) presents diverse clinical and histological features, complicating diagnosis and management.
• While not always indicative of severe systemic disease, CLE significantly impacts patient morbidity and quality of life due to chronic nature, scarring potential, and lesion extent.
• Prompt and effective treatment is essential for managing CLE and mitigating its long-term consequences.

Purpose of the Study:

• To review the varied presentations of lupus erythematosus skin lesions.
• To explore the correlation between cutaneous lupus activity and systemic disease involvement.
• To assess the impact of CLE on patient quality of life and outline available therapeutic options.

Main Methods:

• Comprehensive literature review of studies on cutaneous lupus erythematosus.
• Analysis of clinical and histological classifications of CLE lesions.
• Examination of data linking skin manifestations to systemic lupus erythematosus activity.
• Evaluation of quality of life assessments in CLE patients.
• Summary of current and emerging treatment strategies for CLE.

Main Results:

• CLE exhibits significant heterogeneity in presentation, requiring careful diagnostic approaches.
• A subset of patients with CLE may experience severe systemic complications, necessitating close monitoring.
• CLE demonstrably reduces quality of life, underscoring the need for effective management.
• Various treatment modalities exist, tailored to lesion type, extent, and systemic involvement.

Conclusions:

• Understanding the diverse manifestations of CLE is key to appropriate management.
• Addressing the significant morbidity and quality of life issues associated with CLE is paramount.
• Tailored, effective treatment strategies are vital for improving outcomes in patients with lupus erythematosus skin lesions.